Success Metrics

Clinical Success Rate
79.7%

Based on 47 completed trials

Completion Rate
80%(47/59)
Active Trials
52(32%)
Results Posted
77%(36 trials)
Terminated
12(7%)

Phase Distribution

Ph phase_1
7
4%
Ph phase_3
22
13%
Ph phase_4
12
7%
Ph not_applicable
85
52%
Ph phase_2
31
19%

Phase Distribution

7

Early Stage

31

Mid Stage

34

Late Stage

Phase Distribution157 total trials
Phase 1Safety & dosage
7(4.5%)
Phase 2Efficacy & side effects
31(19.7%)
Phase 3Large-scale testing
22(14.0%)
Phase 4Post-market surveillance
12(7.6%)
N/ANon-phased studies
85(54.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.2%

47 of 66 finished

Non-Completion Rate

28.8%

19 ended early

Currently Active

52

trials recruiting

Total Trials

163

all time

Status Distribution
Active(93)
Completed(47)
Terminated(19)
Other(4)

Detailed Status

Completed47
Recruiting38
Not yet recruiting36
Active, not recruiting14
Terminated12
Withdrawn7

Development Timeline

Analytics

Development Status

Total Trials
163
Active
52
Success Rate
79.7%
Most Advanced
Phase 4

Trials by Phase

Phase 17 (4.5%)
Phase 231 (19.7%)
Phase 322 (14.0%)
Phase 412 (7.6%)
N/A85 (54.1%)

Trials by Status

enrolling_by_invitation53%
active_not_recruiting149%
not_yet_recruiting3622%
completed4729%
terminated127%
unknown42%
withdrawn74%
recruiting3823%

Recent Activity

Clinical Trials (163)

Showing 20 of 163 trialsScroll for more
NCT05900388

A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)

Not Yet Recruiting
NCT03486873Phase 3

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Recruiting
NCT06173544Not Applicable

HIV Engagement and Adolescent Depression Support (HEADS-UP)

Completed
NCT07840378Phase 1

Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Diabetic Foot Ulcers

Not Yet Recruiting
NCT04884815Phase 1

A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson Disease

Active Not Recruiting
NCT06994325Not Applicable

Testing the CHAT Program for Patients With Heart Failure

Completed
NCT07606027Not Applicable

Community Support and Mobile Apps to Help Black Women Control High Blood Pressure After Pregnancy

Not Yet Recruiting
NCT07829445

PRECISE LBCL: Precision Treatment Readiness Through Comprehensive Genomic Sequencing in 1st Line LBCL

Not Yet Recruiting
NCT07206056Phase 1

An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

Recruiting
NCT07825233Not Applicable

Pix-Risk: Early Detection of Rheumatoid Arthritis Via the DETECTRA Platform

Not Yet Recruiting
NCT07823777Not Applicable

Appendectomy as an Adjunct Procedure in Endometriosis Surgery

Not Yet Recruiting
NCT07355218Phase 3

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

Recruiting
NCT07815704Phase 2

Targeting Immune Modulation in High Grade Serous Carcinoma: Combined Effects of Chemotherapy and Atorvastatin

Not Yet Recruiting
NCT07332481Phase 3

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Recruiting
NCT07813507Phase 1

Precision Modulation of Gut Microbiome Enteropathogen Colonization in Critical Illness

Not Yet Recruiting
NCT07112001Not Applicable

A Behavioral mHealth Intervention for People With HIV With Anxiety and Depression

Active Not Recruiting
NCT03244722Not Applicable

Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes

Completed
NCT06813053Not Applicable

A Novel Patient Decision Aid for Surgical Treatment Options in Early-Stage Breast Cancer

Active Not Recruiting
NCT07227909Phase 2

NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy

Not Yet Recruiting
NCT03973281Not Applicable

EASE: The Materna Prep Pivotal Study

Completed

Drug Details

Intervention Type
DRUG
Total Trials
163